Search

Your search keyword '"del Blanco, Bruno García"' showing total 131 results

Search Constraints

Start Over You searched for: Author "del Blanco, Bruno García" Remove constraint Author: "del Blanco, Bruno García"
131 results on '"del Blanco, Bruno García"'

Search Results

1. Performance of balloon-expandable transcatheter bioprostheses in inoperable patients with pure aortic regurgitation of a native valve: The BE-PANTHEON international project

3. Coronary Artery Calcium Score Predicts Major Adverse Cardiovascular Events in Stable Chest Pain

6. Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis

10. Institutional experience and outcomes of transcatheter aortic valve replacement: Results from an international multicentre registry

13. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H24 Analysis

14. 9. INCIDENCIA Y PREDICTORES DE BLOQUEO AURICULOVENTRICULAR Y NECESIDAD DE ESTIMULACIÓN TRAS ABLACIÓN SEPTAL

16. Cost-effectiveness of SAPIEN 3 transcatheter aortic valve implantation in low surgical mortality risk patients in Spain

18. Coste-efectividad del implante percut�neo de v�lvula a�rtica con SAPIEN 3 en pacientes con bajo riesgo de mortalidad quir�rgica en Espa�a

19. EPIC03-BIOSS observational prospective study. Performance analysis of the BIOSS LIM C dedicated stent in coronary bifurcation lesion angioplasty

20. Estudio observacional prospectivo EPIC03-BIOSS. An�lisis del stent dedicado BIOSS LIM C en angioplastias en bifurcaci�n

21. Drug-eluting stents for off-label indications in real clinical world: Evidence based or ‘intuition’ based clinical practice?

22. Bioactive or Drug-Eluting Stents in 75 Years or Older Patients: The BIODES-75 Registry

23. Ajustando a RFR por Preditores de Discordância, “A RFR Ajustada”: Uma Metodologia Alternativa para Melhorar a Capacidade Diagnóstica dos Índices Coronarianos

24. Thrombosis of Second-Generation Drug-Eluting Stents in Real Practice: Results From the Multicenter Spanish Registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2)

25. Justificaci�n y dise�o del estudio Concordancia entre RFF e iFR en lesiones del tronco com�n. Estudio iLITRO-EPIC-07

26. Seguimiento cl�nico del stent coronario largo no c�nico de sirolimus en el mundo real en lesiones de novo. Registro Billar

27. Rationale and design of the Concordance study between FFR and iFR for the assessment of lesions in the left main coronary artery. The ILITRO-EPIC-07 Trial

28. Registro prospectivo del stent liberador de sirolimus con pol�mero estable de fluoroacrilato Angiolite: estudio EPIC02 � RANGO

29. Clinical follow-up of long nontapered sirolimus-eluting coronary stent in real-world patients with de novo lesions. The Billar registry

32. Experiencia multicéntrica con prótesis valvular aórtica transcatéter de segunda generación reposicionable y recuperable

33. Time trend in transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry

34. Multicenter experience with a second-generation fully-retrievable and repositionable transcatheter aortic valve

35. Evolución temporal en el tratamiento transcatéter de la estenosis aórtica: análisis del registro español de TAVI

36. 2. STENT BIOACTIVO FRENTE A STENT FARMACOACTIVO EN PACIENTES DE EDAD AVANZADA CON ENFERMEDAD CORONARIA ESTABLE

39. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial

41. Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement A Propensity Score-Matched Analysis : A Propensity Score-Matched Analysis

42. MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design

43. Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement A Propensity Score-Matched Analysis: A Propensity Score-Matched Analysis

44. 2. STENTBIOACTIVO FRENTE A STENTFARMACOACTIVO EN PACIENTES DE EDAD AVANZADA CON ENFERMEDAD CORONARIA ESTABLE

45. 6. REVASCULARIZACIÓN CON STENTBIOACTIVO FRENTE A STENTFARMACOACTIVO EN PACIENTES DE EDAD MUY AVANZADA

46. THE EFFECT OF PROCEDURAL VOLUME AND EXPERIENCE ON CLINICAL OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE INTERNATIONAL MULTICENTER TAVR REGISTRY

47. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

48. MAGnesium‐based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.

49. Genetic association study of coronary collateral circulation in patients with coronary artery disease using 22 single nucleotide polymorphisms corresponding to 10 genes involved in postischemic neovascularization

50. Arrhythmia Burden in Elderly Patients With Severe Aortic Stenosis as Determined by Continuous Electrocardiographic Recording

Catalog

Books, media, physical & digital resources